These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27356690)

  • 21. Detection of serum melanoma-associated antigen D4 in patients with squamous cell carcinoma of the esophagus.
    Oya H; Kanda M; Koike M; Iwata N; Niwa Y; Shimizu D; Takami H; Sueoka S; Hashimoto R; Ezaka K; Nomoto S; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
    Dis Esophagus; 2016 Aug; 29(6):663-9. PubMed ID: 25951896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated levels of serum metalloproteinase 9 in patients with esophageal squamous cell carcinoma.
    Łukaszewicz-Zajac M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Pol Arch Med Wewn; 2009 Sep; 119(9):558-63. PubMed ID: 19776700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastatic lymph node CHIP expression is a potential prognostic marker for resected esophageal squamous cell carcinoma patients.
    Wen J; Luo KJ; Hu Y; Yang H; Fu JH
    Ann Surg Oncol; 2013 May; 20(5):1668-75. PubMed ID: 23429937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical study on lymph node metastatic recurrence in patients with N0 esophageal squamous cell cancer.
    Sun ZG; Wang Z
    Dis Esophagus; 2011 Apr; 24(3):182-8. PubMed ID: 21073618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer.
    Sharma R; Chattopadhyay TK; Mathur M; Ralhan R
    Oncology; 2004; 67(3-4):300-9. PubMed ID: 15557792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of lymph node status in superficial esophageal carcinoma.
    Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
    Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical implications of the new TNM staging system for thoracic esophageal squamous cell carcinoma].
    Fang WT; Feng J; Mao T; Fu SJ; Chen WH
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):687-91. PubMed ID: 22340051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors and outcome for patients with esophageal squamous cell carcinoma underwent surgical resection alone: evaluation of the seventh edition of the American Joint Committee on Cancer staging system for esophageal squamous cell carcinoma.
    Chen SB; Weng HR; Wang G; Yang JS; Yang WP; Liu DT; Chen YP; Zhang H
    J Thorac Oncol; 2013 Apr; 8(4):495-501. PubMed ID: 23446203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
    Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma.
    Li Y; Yu H; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
    J Surg Oncol; 2011 Nov; 104(6):617-22. PubMed ID: 21744352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: A single-institution experience.
    Li B; Chen H; Xiang J; Zhang Y; Li C; Hu H; Zhang Y
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):778-85; discussion 785-6. PubMed ID: 22889480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer.
    Lu CL; Ji Y; Ge D; Guo J; Ding JY
    Dis Esophagus; 2011 May; 24(4):283-90. PubMed ID: 21087342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
    Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
    Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
    Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
    J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum matrix metalloproteinase-13 as a diagnostic biomarker for cutaneous squamous cell carcinoma.
    Wang H; Li H; Yan Q; Gao S; Gao J; Wang Z; Sun Y
    BMC Cancer; 2021 Jul; 21(1):816. PubMed ID: 34266392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].
    Chen LQ; Hu CY; Zhang HL; He M; Meng XL; Ping YM
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):604-8. PubMed ID: 18210881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating Cell-Free DNA Levels Could Predict Oncological Outcomes of Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma.
    Hsieh CC; Hsu HS; Chang SC; Chen YJ
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of ¹⁸F-fluorodeoxyglucose positron emission tomography in superficial esophageal squamous cell carcinoma.
    Kita Y; Okumura H; Uchikado Y; Sasaki K; Omoto I; Matsumoto M; Setoyama T; Tanoue K; Mori S; Owaki T; Ishigami S; Ueno S; Kajiya Y; Natsugoe S
    Ann Surg Oncol; 2013 May; 20(5):1646-52. PubMed ID: 23238695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated serum levels of human relaxin-2 in patients with esophageal squamous cell carcinoma.
    Ren P; Yu ZT; Xiu L; Wang M; Liu HM
    World J Gastroenterol; 2013 Apr; 19(15):2412-8. PubMed ID: 23613637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
    Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.